Omnicure Clinical Research

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Lung cancer2 trials
• Colorectal cancer1 trial
• Cystic fibrosis1 trial
• Endometrial cancer1 trial
• Gastric and oesophageal cancer1 trial
• Prostate cancer1 trial

Phase

• Phase 2/32 trials
• Phase 1/21 trial
• Phase 21 trial

Status

• Recruiting2 trials
• Active, not recruiting1 trial
• Not yet recruiting1 trial

Lead sponsor

• Eikon Therapeutics2 trials
• Aimmune Nestlé Health Science US R&D, LLC1 trial
• Medicine Invention Design, Inc1 trial

Running trials

• Recruiting

  A Study to Evaluate Safety and Explore Efficacy of New Lipase NHS7108 in Adult Participants With Exocrine Pancreatic Insufficiency.

  NCT07559175· Phase 2· Aimmune Nestlé Health Science US R&D, LLC· Source

  Contact: Anneyd Avalos Penna

• Recruiting

  A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.

  NCT07365319· Phase 2/3· Eikon Therapeutics· Source

  Contact: Elelta Shiferraw

• Active, not recruiting

  Pharmacogenomics IND SNP Clinical Trial - Alectinib and Single Nucleotide Polymorphisms

  NCT05987956· Phase 2/3· Medicine Invention Design, Inc· Source

• Recruiting

  EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

  NCT07262619· Phase 1/2· Eikon Therapeutics· Source

  Contact: Ana C Mamede, PharmD

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Colorectal cancer1 recruiting
• Cystic fibrosis1 recruiting
• Endometrial cancer1 recruiting
• Gastric and oesophageal cancer1 recruiting
• Lung cancer1 recruiting
• Prostate cancer1 recruiting